Interstitial lung disease may occur when an injury to your lungs triggers an abnormal healing response. Ordinarily, your body generates just the right amount of tissue to repair damage. But in interstitial lung disease, the repair process goes awry and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into your bloodstream.
Interstitial lung disease can be triggered by many things — including autoimmune diseases, exposure to organic and inorganic agents in the home or workplace, medications, and some types of radiation. In some cases, the cause is unknown.
Occupational and environmental factors
Long-term exposure to a number of organic and inorganic materials and agents can damage your lungs. These include:
- Asbestos fibers
- Bird protein (live pets and feather-containing products)
- Coal dust
- Grain dust
- Mold from indoor hot tubs, showers and prior water damage
- Silica dust
Medications and radiation
Many drugs can damage your lungs, especially:
- Chemotherapy/immunomodulating drugs, such as methotrexate and cyclophosphamide
- Heart medications, such as amiodarone (Cordarone, Nexterone, Pacerone) and propranolol (Inderal, Inderide, Innopran)
- Some antibiotics, such as nitrofurantoin (Macrobid, Macrodantin, others) and sulfasalazine (Azulfidine)
Some people who have radiation therapy for lung or breast cancer show signs of lung damage months or sometimes years after the initial treatment. The severity of the damage depends on:
- How much of the lung was exposed to radiation
- The total amount of radiation administered
- Whether chemotherapy was also used
- The presence of underlying lung disease
Lung damage can be associated with the following autoimmune diseases:
- Mixed-connective tissue disease
- Pulmonary vasculitis (microscopic polyangiitis)
- Rheumatoid arthritis
- Sjogren's syndrome
- Systemic lupus erythematosus
- Undifferentiated connective tissue disease
After extensive evaluation and testing, an explicit cause may not be found. Disorders without a known cause are grouped together under the label of idiopathic interstitial pneumonias, which are tissue-based classifications.
June 11, 2015
- Schraufnagel DE, et al. Breathing in America: Diseases, Progress and Hope. New York, N.Y.: American Thoracic Society; 2010. http://www.thoracic.org/education/breathing-in-america.pdf. Accessed July 8, 2014.
- Mason RJ, et al. Murray and Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, Pa.: Saunders Elsevier; 2010. http://www.clinicalkey.com. Accessed July 8, 2014.
- King TE. Approach to the adult with interstitial lung disease: Clinical evaluation. http://www.uptodate.com/home. Accessed July 8, 2014.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed July 8, 2014.
- What is idiopathic pulmonary fibrosis? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ipf/. Accessed July 8, 2014.
- Ferri FF. Ferri's Clinical Advisor 2015: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2015. https://www.clinicalkey.com. Accessed July 8, 2014.
- King TE. Treatment of idiopathy pulmonary fibrosis. http://www.uptodate.com/home. Accessed July 8, 2014.
- Pulmonary rehabilitation. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/dci/Diseases/pulreh/pulreh_all.html. Accessed July 8, 2014.
- Ryu J (expert opinion). Mayo Clinic, Rochester, Minn. July 14, 2014.